IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 239 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,550,000 | -72.7% | 1,000,000 | 0.0% | 0.61% | -71.9% |
| Q1 2022 | $16,650,000 | +35.0% | 1,000,000 | +100.0% | 2.16% | +142.9% |
| Q3 2021 | $12,330,000 | -57.9% | 500,000 | -55.6% | 0.89% | -63.9% |
| Q2 2021 | $29,273,000 | +295.5% | 1,125,000 | +355.0% | 2.46% | -12.6% |
| Q1 2020 | $7,401,000 | +21.2% | 247,248 | +12.1% | 2.82% | +87.0% |
| Q4 2019 | $6,105,000 | – | 220,543 | – | 1.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MHR Fund Management | 11,997,103 | $84,459,605 | 11.88% |
| MPM BioImpact LLC | 2,950,118 | $20,768,831 | 4.18% |
| Perceptive Advisors | 14,036,410 | $98,816,326 | 2.86% |
| Velan Capital Investment Management LP | 240,000 | $1,689,600 | 1.57% |
| Parametrica Management Ltd | 96,500 | $679,360 | 1.31% |
| Boxer Capital, LLC | 3,705,133 | $26,084 | 1.21% |
| Soleus Capital Management, L.P. | 1,239,777 | $8,728,030 | 0.97% |
| Opaleye Management Inc. | 421,000 | $2,963,840 | 0.71% |
| 683 Capital Management, LLC | 1,400,000 | $9,856,000 | 0.71% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,758,759 | $12,381,665 | 0.70% |